tenk.fyi

Candel Therapeutics, Inc.

CADLNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$38.2M

30.8% YoY

EPS

$-0.72

58.6% YoY

Cash

$119.7M

16.6% YoY

FY 2025 · As of 2025-12-31